Yoga for wellness: Impact of Asana and Pranayama on Premenstrual Syndrome (PMS)
- Registration Number
- CTRI/2023/12/060710
- Lead Sponsor
- Anushka Pai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
49 apparently healthy female subjects volunteering for the study.
Age group: 18 – 36 years
History of regular menstrual cycle
Females who understand English
With occurrence of PMS (According to premenstrual syndrome scale developed by Gencdogan, having total score = 80)
Females suffering from medical or psychiatric/somatic/ gynecological/ hormonal disorders
Females who are not using any medication or contraceptive pills
Females involved in any kind of athletic programme or practicing other forms of yogic exercises
• Female subjects who were unable to perform yoga due to any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method For HRV assessment <br/ ><br>i. Time domain parameters: <br/ ><br>Mean-RR (mean of RR interval) <br/ ><br>SDNN (standard deviation [SD] of RR interval) <br/ ><br>RMSSD (the square root of the mean of the sum of the squares of the differences between adjacent NN <br/ ><br>intervals) <br/ ><br>NN50 (the number of pairs of adjacent NN intervals differing by >50 ms in the entire recording) <br/ ><br>pNN50 (the percentage of NN50 counts, given by NN50 count divided by total number of all NN intervals) <br/ ><br>ii. Frequency domain parameters: <br/ ><br>TP -Total power <br/ ><br>HF- High frequency (0.15–0.4 Hz) <br/ ><br>LF -Low frequency (0.04–0.15 Hz) <br/ ><br>LF in normalized units (LFnu) <br/ ><br>HF in normalized units (HFnu) <br/ ><br>LF/HF ratioTimepoint: T0- Baseline <br/ ><br>T1- 3 months After commencement of intervention
- Secondary Outcome Measures
Name Time Method Resting Heart Rate <br/ ><br>Deep Breathing Test <br/ ><br>Valsalva maneuver <br/ ><br>Isometric Handgrip test <br/ ><br>Orthostatic HypotensionTimepoint: T0- Baseline <br/ ><br>T1- 3 months After commencement of intervention